This state-of-the-ART talk on antiretroviral drugs and antiretroviral treatment in neonates and infants will focus on: • The considerations when evaluating the safety and dosing of new ARVs in infants and young children • The additional considerations when treating premature infants with antiretroviral drugs for prophylaxis or treatment • The evolving paradigm around the use of antiretroviral drugs for prevention and treatment of HIV during the newborn period • The role of transplacental transfer of antiretroviral drugs in loading the neonate in the peripartum period • Discussion on currently available antiretroviral drugs used to treat neonates/infants • Discussion on antiretroviral drugs and delivery systems that are in the pipeline for prevention and treatment of HIV across the pediatric age range